Abstract
Purpose
Cancerous involvement of a ureter is sometimes encountered in pelvic surgery for malignancy. We usually perform transureteroureterostomy (TUU) in cases of unilateral lower ureteral cancerous involvement. We report the outcomes in patients treated with TUU in our institute.
Methods
We retrospectively reviewed the medical records of 11 patients who underwent TUU between June 2006 and September 2015.
Results
The primary disease was colon cancer in five patients, rectal cancer in four, and uterine cervical cancer and ovarian cancer in one patient each. Early postoperative complications relevant to TUU occurred in four patients; however, three patients were managed conservatively and recovered quickly. Only one patient developed ureteral obstruction, which resulted from anastomotic hematoma. Follow-up periods ranged from 5 to 78 months with a median of 28 months. The median estimated glomerular filtration rate before and after TUU was 59 ml/min (range, 31–90 ml/min) and 62.0 ml/min (range, 43–127 mL/min), respectively. No patients experienced worsening of their renal function or recurrent urinary tract infection.
Conclusions
Short-term outcomes are good and long-term renal function is maintained following TUU. TUU is considered a feasible technique for ureteral reconstruction for pelvic malignancy, and TUU has great potential in the era of multimodal therapy.
References
Joung JY, Jeong IG, Seo HK, Kim TS, Han KS, Chung J, Lee KH (2008) The efficacy of transureteroureterostomy for ureteral reconstruction during surgery for a non-urologic pelvic malignancy. J Surg Oncol 98:49–53. doi:10.1002/jso.21086
Wells CA (1956) The use of the intestine in urology, omitting ureterocolic anastomosis. Br J Urol 28:335–350
Armatys SA, Mellon MJ, Beck SD, Koch MO, Foster RS, Bihrle R (2009) Use of ileum as ureteral replacement in urological reconstruction. J Urol 181:177–181. doi:10.1016/j.juro.2008.09.019
Iwaszko MR, Krambeck AE, Chow GK, Gettman MT (2010) Transureteroureterostomy revisited: long-term surgical outcomes. J Urol 183:1055–1059. doi:10.1016/j.juro.2009.11.031
Pisters PW, Pettaway CA, Liu P, Matin SF, Ward JF, Leibovici D (2012) Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? J Surg Oncol 106:62–65. doi:10.1002/jso.23039
Strup SE, Sindelar WF, Walther MM (1996) The use of transureteroureterostomy in the management of complex ureteral problems. J Urol 155:1572–1574
Sugarbaker PH, Gutman M, Verghese M (2003) Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy. Int J Color Dis 18:40–44. doi:10.1007/s00384-002-0399-2
Barry JM (2005) Surgical atlas transureteroureterostomy. BJU Int 96:195–201. doi:10.1111/j.1464-410X.2005.05552.x
Tanaka S, Martling A, Lindholm J, Holm T, Palmer G (2015) Remaining cancer cells within the fibrosis after neo-adjuvant treatment for locally advanced rectal cancer. Eur J Surg Oncol 41:1204–1209. doi:10.1016/j.ejso.2015.05.019
Rainwater LM, Leary FJ, Rife CC (1991) Transureteroureterostomy with cutaneous ureterostomy: a 25-year experience. J Urol 146:13–15
Mure PY, Mollard P, Mouriquand P (2000) Transureteroureterostomy in childhood and adolescence: long-term results in 69 cases. J Urol 163:946–948
Richter S, Kollmar O, Lindemann W, Schilling MK (2007) Transureteroureterostomy allows renal sparing radical resection of advanced malignancies with rectosigmoid invasion. Int J Color Dis 22:949–953. doi:10.1007/s00384-006-0235-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The authors declare that no funding support was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Kawamura, J., Tani, M., Sumida, K. et al. The use of transureteroureterostomy during ureteral reconstruction for advanced primary or recurrent pelvic malignancy in the era of multimodal therapy. Int J Colorectal Dis 32, 135–138 (2017). https://doi.org/10.1007/s00384-016-2672-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-016-2672-9